A new algorithm to convert a normal antibody into the corresponding catalytic antibody.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
03 2020
Historique:
received: 05 07 2019
accepted: 31 12 2019
entrez: 2 4 2020
pubmed: 2 4 2020
medline: 25 11 2020
Statut: epublish

Résumé

Over thousands of monoclonal antibodies (mAbs) have been produced so far, and it would be valuable if these mAbs could be directly converted into catalytic antibodies. We have designed a system to realize the above concept by deleting Pro

Identifiants

pubmed: 32232151
doi: 10.1126/sciadv.aay6441
pii: aay6441
pmc: PMC7096177
doi:

Substances chimiques

Amyloid beta-Peptides 0
Antibodies, Catalytic 0
Antibodies, Monoclonal 0
Immunoglobulin Light Chains 0
Peptide Fragments 0
Recombinant Proteins 0
amyloid beta-protein (1-40) 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaay6441

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

J Biol Chem. 2008 Jan 11;283(2):899-907
pubmed: 17991752
J Am Chem Soc. 2011 Sep 28;133(38):15015-24
pubmed: 21861493
FASEB Bioadv. 2019 Jan 29;1(2):93-104
pubmed: 32123823
Biotechnol Bioeng. 2004 Apr 20;86(2):217-25
pubmed: 15052642
FEBS J. 2010 Sep;277(18):3823-32
pubmed: 20718866
FASEB J. 2015 Jun;29(6):2347-58
pubmed: 25713031
Biochem J. 2006 May 1;395(3):473-81
pubmed: 16422668
J Biol Chem. 2015 Apr 17;290(16):10229-41
pubmed: 25724648
Science. 1986 Dec 19;234(4783):1566-70
pubmed: 3787261
J Biol Chem. 2017 Jan 13;292(2):417-434
pubmed: 27872188
Mol Immunol. 2009 Nov;47(1):87-95
pubmed: 19201029
J Biol Chem. 2008 Feb 22;283(8):4714-22
pubmed: 18086674
Science. 1989 Jun 9;244(4909):1158-62
pubmed: 2727702
Science. 1986 Dec 19;234(4783):1570-3
pubmed: 3787262
Nature. 1975 Aug 7;256(5517):495-7
pubmed: 1172191
FASEB J. 2017 Apr;31(4):1668-1677
pubmed: 28096233
Biochemistry. 2006 Jan 10;45(1):324-30
pubmed: 16388609
J Biol Chem. 1991 Aug 25;266(24):15571-4
pubmed: 1908455
Biochem Biophys Res Commun. 1994 Oct 14;204(1):57-62
pubmed: 7945392
J Biol Chem. 2009 Nov 27;284(48):33079-87
pubmed: 19801545
Biochemistry (Mosc). 2011 Sep;76(9):1065-72
pubmed: 22082277
Nat Med. 1999 Sep;5(9):1044-7
pubmed: 10470082
J Biol Chem. 2009 Sep 4;284(36):24622-33
pubmed: 19542217
Biochimie. 2010 May;92(5):545-54
pubmed: 20138955
FASEB J. 2016 Feb;30(2):895-908
pubmed: 26527062
Methods Enzymol. 1997;289:44-67
pubmed: 9353717
Mol Immunol. 2016 Jan;69:33-43
pubmed: 26655427
J Biol Chem. 2004 Sep 17;279(38):39611-9
pubmed: 15269209
J Biosci Bioeng. 2004;97(3):143-52
pubmed: 16233607
Mol Immunol. 1999 Dec;36(18):1215-22
pubmed: 10684961
J Biol Chem. 2013 Jul 5;288(27):19558-68
pubmed: 23677996
J Biol Chem. 1994 Dec 23;269(51):32389-93
pubmed: 7798238
FASEB J. 2012 Apr;26(4):1607-15
pubmed: 22205784
FEBS J. 2005 Sep;272(17):4497-505
pubmed: 16128818
J Immunol Methods. 2002 Nov 1;269(1-2):283-98
pubmed: 12379368
Appl Microbiol Biotechnol. 2007 Dec;77(3):597-603
pubmed: 17899065
Science. 1992 May 1;256(5057):665-7
pubmed: 1585181

Auteurs

Emi Hifumi (E)

Oita University, Research Promotion Institute, 700 Dannoharu, Oita-shi, Oita 870-1192, Japan.

Hiroaki Taguchi (H)

Suzuka University of Medical Science, Faculty of Pharmaceutical Sciences, 3500-3 Minamitamagaki-cho, Suzuka 510-0293, Japan.

Haruna Tsuda (H)

Oita University, Research Promotion Institute, 700 Dannoharu, Oita-shi, Oita 870-1192, Japan.
Oita University, Department of Applied Chemistry, Faculty of Engineering, 700 Dannoharu, Oita-shi, Oita 870-1192, Japan.

Tetsuro Minagawa (T)

Oita University, Research Promotion Institute, 700 Dannoharu, Oita-shi, Oita 870-1192, Japan.
Oita University, Department of Applied Chemistry, Faculty of Engineering, 700 Dannoharu, Oita-shi, Oita 870-1192, Japan.

Tamami Nonaka (T)

Oita University, Research Promotion Institute, 700 Dannoharu, Oita-shi, Oita 870-1192, Japan.

Taizo Uda (T)

Oita University, Research Promotion Institute, 700 Dannoharu, Oita-shi, Oita 870-1192, Japan.
Nanotechnology Laboratory, Institute of Systems, Information Technologies and Nanotechnologies (ISIT), 4-1 Kyudai-shinmachi, Fukuoka 879-5593, Japan.

Articles similaires

Selecting optimal software code descriptors-The case of Java.

Yegor Bugayenko, Zamira Kholmatova, Artem Kruglov et al.
1.00
Software Algorithms Programming Languages
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Classifications MeSH